These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18795266)

  • 1. Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.
    Woolley ML; Waters KA; Gartlon JE; Lacroix LP; Jennings C; Shaughnessy F; Ong A; Pemberton DJ; Harries MH; Southam E; Jones DN; Dawson LA
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):343-54. PubMed ID: 18795266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CX691, as an AMPA receptor positive modulator, improves the learning and memory in a rat model of Alzheimer's disease.
    Mozafari N; Shamsizadeh A; Fatemi I; Allahtavakoli M; Moghadam-Ahmadi A; Kaviani E; Kaeidi A
    Iran J Basic Med Sci; 2018 Jul; 21(7):724-730. PubMed ID: 30140412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
    Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator.
    Ward SE; Beswick P; Calcinaghi N; Dawson LA; Gartlon J; Graziani F; Jones DN; Lacroix L; Selina Mok MH; Oliosi B; Pardoe J; Starr K; Woolley ML; Harries MH
    Br J Pharmacol; 2017 Mar; 174(5):370-385. PubMed ID: 28009436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.
    Bernard K; Danober L; Thomas JY; Lebrun C; Muñoz C; Cordi A; Desos P; Lestage P; Morain P
    CNS Neurosci Ther; 2010 Oct; 16(5):e193-212. PubMed ID: 21050420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1/2 and Arc genes in rats.
    Potasiewicz A; Faron-Gorecka A; Popik P; Nikiforuk A
    Behav Brain Res; 2021 Jul; 409():113338. PubMed ID: 33940049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the AMPA receptor modulator S 18986 on measures of cognition and oxidative stress in aged rats.
    Kelly SJ; Bernard K; Muñoz C; Lawrence RC; Thacker J; Grillo CA; Piroli GG; Reagan LP
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):225-35. PubMed ID: 18762915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.
    Fone KCF; Watson DJG; Billiras RI; Sicard DI; Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Mol Neurobiol; 2020 May; 57(5):2144-2166. PubMed ID: 31960362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile.
    Ward SE; Harries MH; Aldegheri L; Bradford AM; Ballini E; Dawson L; Lacroix L; Pardoe J; Starr K; Weil A; Waters K; Atack JR; Woolley M
    J Psychopharmacol; 2020 Jan; 34(1):93-102. PubMed ID: 31766938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats.
    Mishima K; Iwasaki K; Tsukikawa H; Matsumoto Y; Egashira N; Abe K; Egawa T; Fujiwara M
    Jpn J Pharmacol; 2000 Oct; 84(2):163-73. PubMed ID: 11128039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.
    Nikiforuk A; Popik P; Drescher KU; van Gaalen M; Relo AL; Mezler M; Marek G; Schoemaker H; Gross G; Bespalov A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):665-73. PubMed ID: 20739457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats.
    Calabrese F; Savino E; Mocaer E; Bretin S; Racagni G; Riva MA
    Pharmacol Res; 2017 Jul; 121():59-69. PubMed ID: 28442348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.
    Wang D; Noda Y; Zhou Y; Mouri A; Mizoguchi H; Nitta A; Chen W; Nabeshima T
    Neuropsychopharmacology; 2007 Jun; 32(6):1261-71. PubMed ID: 17133263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat.
    Rosi S; Giovannini MG; Lestage PJ; Muñoz C; Corte LD; Pepeu G
    Neurosci Lett; 2004 May; 361(1-3):120-3. PubMed ID: 15135908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
    De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic scopolamine-injection-induced cognitive deficit on reward-directed instrumental learning in rat is associated with CREB signaling activity in the cerebral cortex and dorsal hippocampus.
    Shi Z; Chen L; Li S; Chen S; Sun X; Sun L; Li Y; Zeng J; He Y; Liu X
    Psychopharmacology (Berl); 2013 Nov; 230(2):245-60. PubMed ID: 23722831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.